Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sanofi and Regeneron report data from phase II Japanese study of alirocumab

April 3, 2014

Novel GPR119 agonists developed by Boehringer Ingelheim and Neurocrine Biosciences

April 3, 2014

FDA advisory committee recommends approval of Afrezza

April 2, 2014

New MCHR-1 antagonists presented by Bristol-Myers Squibb

April 2, 2014

Japanese researchers design new MetAP 2 inhibitors

April 1, 2014

Amgen presents new GK-GKRP disruptors for type 2 diabetes

April 1, 2014

Pivotal phase III Kiobrina study does not meet primary endpoint

March 31, 2014

Phase III fertility study of Pergoveris in poor ovarian responders begins

March 31, 2014

Gemigliptin/metformin fixed-dose combination shows promise in healthy volunteers

March 28, 2014

Pfizer achieves primary endpoint in phase IIIb study of Genotropin

March 28, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...